Medikabazaar, India’s leading B2B healthcare supply chain platform, reported a 57% year-on-year revenue increase to ₹592 crore for the quarter ended June 2026.
The strong performance, driven by rising demand across its network, positions the company to approach its ambitious ₹3,000 crore revenue target for fiscal year 2027.
The results highlight the accelerating digitization of India’s pharmaceutical distribution network.
As a private company, Medikabazaar does not trade on public exchanges, but its growth trajectory serves as a key indicator for the broader health-tech and logistics sectors.
Investors monitoring the Indian market view such private-sector momentum as a sign of underlying strength in healthcare infrastructure and digital adoption.
This quarter’s performance follows a trend of robust earnings from other Indian firms.